|
Welcome to the Formulation Design & Development Section |
 |
Affiliated Focus Groups
Animal
Pharmaceutics & Technology
Dermatopharmaceutics
Excipients
Freezing
and Drying Technologies
Generic
Pharmaceuticals
Inhalation
and Nasal Technology
Lipid-Based
Drug Delivery Systems
Modified
Release
Nanotechnology
Nucleic Acid Based Therapeutics
Nutraceutical
Ocular
Drug Delivery & Disposition
Pharmaceutical Packaging Development
Preformulation
Process
Development
Sterile
Products
Formulation Design & Development
The Formulation Design & Development Section is comprised of members from many
diverse backgrounds in industry, regulatory and academia who share a common interest
in the area of formulation design, research and development - a multidisciplinary
field drawing upon the physical, chemical, biological and engineering sciences.
The primary goal of this section is to unite multiple scientific disciplines in
a forum where they can share experimental results, consider new formulation and
dosage form technologies, and discuss issues and concerns regarding the design and
development of formulations/drug products for all dosage forms. This Section collaboratively
interfaces with other sections which focus on pre-formulation, biopharmaceutics,
formulation strategies, and manufacturing process optimization.
Aspects of formulation design and development include the study of dosage forms
for drug delivery via all routes of administration wherein the dosage form encompasses
the formulation, process by which it is made, and primary packaging. The Section’s
focus on development includes product design, delivery systems and technology, stability,
quality, and performance both in vitro and in vivo that is appropriate to its development
stage.
FDD Section Vision
The Formulation Design and Development Section will be the premier worldwide forum
for scientists dedicated to the design and development of all dosage forms.
FDD Section Mission
The Formulation Design and Development Section provides a dynamic international
forum for the exchange of formulation-related knowledge among scientists to enhance
their contributions to health. We offer timely formulation-related scientific programs,
on-going education, opportunities for networking, and professional development by:
- Providing forums for the free interchange and dissemination of scientific knowledge,
particularly in the area of formulation design and development;
- Fostering the scientific and technical growth of scientists in the discipline;
- Promoting and recognizing excellence in the discipline;
- Encouraging the support of basic academic, industrial, and regulatory research programs
and the development of mutually beneficial relationships;
- Encouraging students to enter the discipline by strengthening and increasing the
viability of academic programs in formulation design and development;
- Collaborating with and supporting other AAPS sections, focus groups, and other professional/scientific
organizations; and
- Informing the public of major advances in formulation design and development.
FDD By-Laws
FDD Section Volunteer Guidelines and Responsibilities
|
FDD Newsletter
Section Connection
Please check back frequently for more information about the brand new FDD Section!
The archived websites for the Pharmaceutics
and Drug Delivery (PDD) Section and the
Pharmaceutical Technologies (PT) Section
are still available for access.
|
|
|
Chair
Colin M. Minchom, Ph.D.
Patheon Inc.
Mississauga, ON Canada
| Chair-Elect
Dave Wallick, Ph.D.
The Dow Chemical Company
Midland, MI UNITED STATES
| Vice Chair
Samantha Lai, Ph.D.
Tamlylin
Mountain View, CA United States
| Secretary/Treasurer
Lori R. Hilden, Ph.D.
Eli Lilly & Company
Indianapolis, IN
| Past Chair
Mansoor A. Khan, R.Ph., Ph.D.
FDA/CDER/DPQR, HFD-941
Silver Spring, MD UNITED STATES
| Member at Large
David Y. Mitchell, Ph.D.
Mitchell Pharmaceutical Consulting, LLC
Lafayette, CO United States
| National Biotechnology Conference Screeners Committee
Yoon Yeo
Purdue University
West Lafayette, IN United States
| Annual Meeting Screeners Committee
Jayanth Panyam
University of Minnesota
Minneapolis, MN UNITED STATES
| Annual Meeting Program Committee
Dave Wallick, Ph.D.
The Dow Chemical Company
Midland, MI UNITED STATES
| Awards Committee
Kenneth R. Morris, Ph.D.
University of Hawaii at Hilo
Hilo, HI
| Content Advisory Cmte
Joseph P. Reo, Ph.D.
Schering-Plough Corporation
Memphis, TN United States
| National Biotech Progrming Committee
Feroz Jameel
Amgen
Thousand Oaks, CA
| Student/Postdoc Committee
Bhaskara R. Jasti, Ph.D.
University of the Pacific
Stockton, CA United States
| Fellows Committee
Mansoor A. Khan, R.Ph., Ph.D.
FDA/CDER/DPQR, HFD-941
Silver Spring, MD UNITED STATES
| Nominations Committee
Colin M. Minchom, Ph.D.
Patheon Inc.
Mississauga, ON Canada
| Program Coordination Committee
Dave Wallick, Ph.D.
The Dow Chemical Company
Midland, MI UNITED STATES
| Strategic Planning
Indra K. Reddy, Ph.D.
Texas A&M Health Science Center College of Pharmacy
Kingsville, TX United States
| Strategic Planning
Otilia M. Koo, Ph.D.
Bristol-Myers Squibb Company
New Brunswick, NJ United States
| Student Rep
Ravikanth Kona
University of Maryland
Baltimore, MD United States
| Finance Committee
Anil Kane, Ph.D.
Patheon, Inc.
Mississauga, ON Canada
| Webmasters Committee
Naveen K. Bejugam, Ph.D.
SRI International
Menlo Park, CA United States
| Communications Committee
Naveen K. Bejugam, Ph.D.
SRI International
Menlo Park, CA United States
| Finance Committee
Karen Coppens, MBA
Dow Chemical Co.
Midland, MI
| Member Strategic Oversight Committee
Rakhi Shah, Ph.D.
FDA/CDER/DPQR
Silver spring, MD UNITED STATES
| Staff Liaison
Grace Jones
AAPS
Arlington, VA United States
| Staff Liaison
Sharon R. Pichon
AAPS
Arlington, VA
| Staff Liaison
Maria Nadeau
AAPS
Arlington, VA United States
| Animal Pharmaceutics & Technology Focus Group
Dr. Jay C. Brumfield
Merck
Westfield, NJ United States
| Dermatopharmaceutics Focus Group
Mr. Steven A. Giannos
Chrono Therapeutics, Inc.
Quincy, MA UNITED STATES
| Excipients Focus Group
Dr. Thomas P. Farrell
Colorcon
West Point, PA UNITED STATES
| Freezing & Drying Technologies Focus Group
Feroz Jameel
Amgen
Thousand Oaks, CA
| Generic Pharmaceuticals Focus Group
Saji K. Thomas
Par Pharmaceuticals
Scarsdale, NY United States
| Inhalation & Nasal Technology Focus Group
Michael T. Riebe, Ph.D.
Merck & Co., Inc.
Collegeville, PA United States
| Lipid-Based Drug Delivery Systems Focus Group
Paul M. Bummer, Ph.D.
University of Kentucky
Lexington, KY UNITED STATES
| Modified Release Focus Group
John R. Crison, Ph.D.
Private Consulting
Carlsbad, CA United States
| Nanotechnology Focus Group
Panayiotis P. Constantinides, Ph.D.
Biopharmaceutical and Drug Delivery Consulting, LLC
Gurnee, IL UNITED STATES
| Nutraceuticals Focus Group
Jairaj Mehta
JM Pharma, LLC
Peoria, AZ UNITED STATES
| Nucleic Acid Based Therapeutics Focus Group
Sean M. Sullivan, Ph.D
Vical, Inc.
San Diego, CA United States
| Ocular Drug Delivery & Disposition Focus Group
Adrian Raiche, Ph.D.
SurModics Pharmaceuticals
Birmingham, AL United States
| Preformulation Focus Group
Tapan K. Das, Ph.D.
Pfizer
Chesterfield, MO United States
| Process Development Focus Group
Victor M. Wong
Wyeth
Pearl River, NY United States
| Sterile Products Focus Group
Qiang Ye, Ph.D.
Otonomy, Inc.
San Diego, CA United States
|
|